Search

Author/Creator Losantos, Itsaso

2. Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity. (19th May 2021)

Authors:
Mozo, Yasmina; Bueno, David; Sisinni, Luisa; Fernández-Arroyo, Alba; Rosich, Blanca; Martínez, Antonio Pérez; Benítez-Carabante, María Isabel; Alonso, Laura; Uría, María Luz; Heredia, Cristina Díaz de; Mestre-Duran, Carmen; Pascual, Cristina Ferreras Bárbara; Torres, Juan; Losantos, Itsaso; Escud...
Journal:
Pediatric hematology and oncology
Issue:
Volume 38:Number 4(2021)
Page Start:
331
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience. (3rd October 2022)

Authors:
Fernández-Fournier, Mireya; Kerguelen, Ana; Rodríguez de Rivera, Francisco Javier; Lacruz, Laura; Jimeno, Santiago; Losantos, Itsaso; Hernández-Maraver, Dolores; Puertas, Inmaculada; Tallon-Barranco, Antonio; Viejo, Aurora; Frank García, Ana; Díez-Tejedor, Exuperio
Journal:
Expert review of neurotherapeutics
Issue:
Volume 22:Number 10(2022)
Page Start:
897
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗